Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma-Reference-Cited by-同舟云学术

Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma

Published:2018-05-14 Issue:5-6 Volume:25 Page:106-116
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Barrett John A.,Cai Hongliang,Miao John,Khare Pranay D.,Gonzalez Paul,Dalsing-Hernandez Jessica,Sharma Geeta,Chan Tim,Cooper Laurence J.N,Lebel Francois

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/s41417-018-0019-0.pdf

Reference47 articles.

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.

2. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol. 2015;17(Suppl 4):iv1–iv62.

3. Norden AD, Drappatz J, Muzikansky A, David K, Gerard M, McNamara MB, et al. An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma. J Neurooncol. 2009;92:149–55.

4. Goldmann J, Kwidzinski E, Brandt C, Mahlo J, Richter D, Bechmann I. T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J Leukoc Biol. 2006;80:797–801.

5. Klinke DJ 2nd. A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12. Mol Cancer. 2010;9:242.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity;Frontiers in Immunology;2024-09-03

2. Advances in gene therapy for high-grade glioma: a review of the clinical evidence;Expert Review of Neurotherapeutics;2024-08

3. Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities;Signal Transduction and Targeted Therapy;2024-05-22

4. Targeted delivery of interleukin‐12 plasmid into HepG2 cells through folic acid conjugated graphene oxide nanocarrier;Biotechnology Progress;2024-05-16

5. Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy;Cellular & Molecular Immunology;2024-04-11